NAD+ vs sermorelin
Same longevity market. Different molecules.
NAD+ and sermorelin are not two versions of the same treatment. NAD+ is a coenzyme involved in cellular energy reactions; sermorelin is a peptide that stimulates growth-hormone release. Both are marketed by longevity providers, but that label does not prove either extends human life. They need different evidence, clinical assessments and product comparisons. The useful question is not which one is the universal winner, but what the proposed treatment is intended to achieve, what human evidence supports that outcome and what the actual plan costs.
| Question | NAD+ | Sermorelin |
|---|---|---|
| What is it? | Nucleotide coenzyme; not a peptide. | GHRH analogue peptide. |
| What is its role or mechanism? | NAD+/NADH participates in cellular energy reactions. | Signals the pituitary to release growth hormone. |
| What did our cited human evidence measure? | A small IV study measured metabolites over hours. | Small studies measured hormone release and selected short-term outcomes. |
| Does that establish longer life? | No. | No. |
| What do we compare? | Clinician-reviewed compounded injection plans. | Clinician-reviewed compounded injection plans. |
| Where can I see prices? | NAD+ cost guide | Sermorelin cost guide |
Evidence: Grant et al.: human NAD+ IV pilot (2019) Spoudeas et al.: GHRH response study (1994) Vittone et al.: GHRH in older men (1997)
Is NAD+ better than peptides?
“Peptides” is a chemical family, not one treatment. A comparison between NAD+ and every peptide would combine unrelated products and outcomes. For sermorelin specifically, the biological mechanism differs from NAD+'s cellular role. Neither mechanism alone establishes the benefit a buyer hopes for. Grant et al.: human NAD+ IV pilot (2019) Spoudeas et al.: GHRH response study (1994)
Choose a defined question, such as what evidence supports the proposed outcome, rather than comparing broad “anti-aging” claims.
Can you use NAD+ and sermorelin together?
The source packet for this guide does not establish the safety or effectiveness of combining the two. A provider selling a bundle is not a clinical study. We do not recommend combinations or provide a stacking schedule; discuss the exact products, medical history and monitoring with the clinician responsible for the prescription.
Both product-specific uncertainty and compounded-drug quality matter. FDA: risks of compounded drugs
Why are both covered under longevity?
Longevity is our editorial market, not an assertion that every listed product makes people live longer. Keeping NAD+ and sermorelin under separate category pages lets readers understand each before comparing providers. Other products can be added later only when they have their own verified evidence and useful purchase information.
Weight-loss care belongs in the existing GLP-1 Picks publication, and menopause care and TRT have dedicated HRT Picks coverage. This site does not turn hair loss or sexual-performance products into longevity treatments merely because the same provider sells them. Read our publication scope.
These are products marketed in the longevity category, not established lifespan-extension treatments. Compounded drugs are not FDA-approved. This publication compares public information; a clinician must assess individual suitability. How we compare.